Neutral
BLI Banque de Luxembourg Investments lowered its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 5.7% in the fourth ...
Bullish
West Pharmaceutical Services has appointed Michel Lagarde as President and CEO, effective August 31, 2026. Lagarde joins from Thermo Fisher Scientific...
Morgan Stanley has increased its price target for West Pharmaceutical Services (WST) to $325 from $315, while maintaining an Equalweight rating on the...
Neutral
West Pharmaceutical Services has successfully restored its operations following a recent cyberattack. The company, based in Exton, Pa., announced the ...
Neutral
West Pharmaceutical Services announced that it has fully restored operations across all its sites after experiencing a cybersecurity attack earlier th...
Neutral
Zacks Research analysts have increased their Q2 2026 EPS estimates for West Pharmaceutical Services (NYSE:WST) from $1.98 to $2.06 and maintained a "S...
Neutral
Bank Julius Baer & Co. Ltd Zurich trimmed its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 26.7% during the 4t...
West Pharmaceutical Services (NYSE:WST) experienced a significant cyberattack involving data exfiltration and system encryption, leading to a temporar...